Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial

Publication date: Available online 7 April 2021Source: The Lancet HaematologyAuthor(s): Jo Howard, Kenneth I Ataga, Robert C Brown, Maureen Achebe, Videlis Nduba, Amal El-Beshlawy, Hoda Hassab, Irene Agodoa, Margaret Tonda, Sarah Gray, Joshua Lehrer-Graiwer, Elliott Vichinsky
Source: The Lancet Haematology - Category: Hematology Source Type: research